Neuronetics_logo-RGB purple.png
Neuronetics to Present at the Canaccord Genuity 42nd Annual Growth Conference
July 28, 2022 16:30 ET | Neuronetics
MALVERN, Pa., July 28, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics and Alleviant Health Centers Announce Exclusive Partnership
July 25, 2022 08:31 ET | Neuronetics
Partnership Will Bring Non-drug NeuroStar® Advanced Therapy for Mental Health to Thousands More Patients MALVERN, Pa., July 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a...
Neuronetics_logo-RGB purple.png
Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call
July 19, 2022 08:30 ET | Neuronetics
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics_logo-RGB purple.png
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression
July 19, 2022 07:00 ET | Neuronetics
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) --  Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics Recognized as Top Non-Invasive Devices Provider in 2022
July 13, 2022 08:31 ET | Neuronetics
MALVERN, Pa., July 13, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics_logo-RGB purple.png
Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health
July 11, 2022 16:46 ET | Neuronetics
MALVERN, Pa., July 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
Neuronetics_logo-RGB purple.png
Neuronetics to Present at the William Blair 42nd Annual Growth Stock Conference
May 25, 2022 16:30 ET | Neuronetics
MALVERN, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics_logo-RGB purple.png
New Peer-Reviewed Data Continue to Further Best Practices with NeuroStar® Advanced Therapy
May 17, 2022 08:31 ET | Neuronetics
Published in Brain Stimulation Journal, study describes insights from world’s largest depression registry MALVERN, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a...
Neuronetics_logo-RGB purple.png
Neuronetics Reports First Quarter 2022 Financial and Operating Results
May 12, 2022 07:30 ET | Neuronetics
MALVERN, Pa., May 12, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...
Neuronetics_logo-RGB purple.png
Neuronetics and Transformations Care Network Announce Extended Commercial Partnership
May 11, 2022 16:30 ET | Neuronetics
MALVERN, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever...